Prolonged lymphocytosis during ibrutinib therapy is associated with distinct molecular characteristics and does not indicate a suboptimal response to therapy.
Times cited: 174
Genetic heterogeneity of diffuse large B-cell lymphoma.
Proceedings of the National Academy of Sciences of the United States of America.
Times cited: 299